Here’s some of HealthDay’s top stories for Friday, July 23: Arguing for & against approval of controversial Alzheimer’s drug. The FDA earlier this month gave its OK to the first new Alzheimer’s drug in years — despite its own panel voting 10-1 against approval. Now, some doctors and hospitals areContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A drug that eases hallucinations in people with Parkinson’s disease may be able to do the same for those with dementia, a new clinical trial finds. The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusionsContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — A traumatic brain injury (TBI) can cripple patients for the rest of their lives, but new research suggests that many people with moderate-to-severe TBI have better-than-expected long-term outcomes. The findings show that decisions about halting life-sustaining treatment for these patients should not beContinue Reading

FRIDAY, July 23, 2021 (HealthDay News) — Digestive issues are common after spinal cord injury and can lead to chronic constipation and incontinence. But robotic exoskeleton-assisted walking can improve matters in people with such injuries, researchers say. In an earlier survey, more than a third of men with spinal cordContinue Reading

In a HealthDay Now interview, Mabel Jong heard from experts with inside knowledge on the FDA’s controversial approval of aducanumab. First up is Dr. G. Caleb Alexander, a professor at Johns Hopkins who served on the FDA advisory committee that nearly unanimously advised against approving Biogen’s controversial new Alzheimer’s drug. Then, a conversation between Dr. Anton Porsteinsson, a principal investigator for the drug trial, and Dr. Ken Lin, a primary care physician who, like most clinicians surveyed in a new poll, has his concerns and has said he will not prescribe the new drug.Continue Reading

THURSDAY, July 22, 2021 (HealthDay News) — Black Americans admitted for inpatient hospital care are far more likely than white patients to experience safety-related health complications — even when both are treated in the same facility, a new report warns. And having good insurance didn’t appear to bridge racial differencesContinue Reading